Augmedix, Inc. Share Price

Equities

AUGX

US05105P1075

Business Support Services

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
2.85 USD +2.15% Intraday chart for Augmedix, Inc. -4.68% -51.28%
Sales 2024 * 61.1M 5.09B Sales 2025 * 85.1M 7.1B Capitalization 139M 11.58B
Net income 2024 * -26M -2.17B Net income 2025 * -19M -1.58B EV / Sales 2024 * 2 x
Net cash position 2024 * 16.87M 1.41B Net cash position 2025 * - 0 EV / Sales 2025 * 1.63 x
P/E ratio 2024 *
-5.48 x
P/E ratio 2025 *
-7.57 x
Employees 1,430
Yield 2024 *
-
Yield 2025 *
-
Free-Float 89.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.15%
1 week-4.68%
Current month-30.32%
1 month-27.20%
3 months-38.18%
6 months-37.09%
Current year-51.28%
More quotes
1 week
2.61
Extreme 2.61
3.11
1 month
2.61
Extreme 2.61
4.31
Current year
2.61
Extreme 2.61
6.25
1 year
2.61
Extreme 2.61
6.25
3 years
1.01
Extreme 1.01
6.25
5 years
1.01
Extreme 1.01
10.00
10 years
1.01
Extreme 1.01
10.00
More quotes
Managers TitleAgeSince
Founder 40 01/12/01
Chief Executive Officer 65 01/18/01
Director of Finance/CFO 55 01/20/01
Members of the board TitleAgeSince
Director/Board Member 60 09/22/09
Director/Board Member 60 01/21/01
Director/Board Member 61 10/23/10
More insiders
Date Price Change Volume
26/24/26 2.85 +2.15% 320,653
25/24/25 2.79 -2.11% 244,808
24/24/24 2.85 +0.35% 263,740
23/24/23 2.84 -5.02% 141,061
22/24/22 2.99 0.00% 182,445

Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST

More quotes
Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
2.85 USD
Average target price
6.1 USD
Spread / Average Target
+114.04%
Consensus